about
Interventions for protecting renal function in the perioperative periodSafety of off-label erythropoiesis-stimulating agents for critically ill patientsErythropoiesis-stimulating agents for anaemia in chronic heart failure patientsPhosphorylation of Bcl-associated death protein (Bad) by erythropoietin-activated c-Jun N-terminal protein kinase 1 contributes to survival of erythropoietin-dependent cellsErythropoietin and diabetes mellitusStem cell guidance through the mechanistic target of rapamycinErythropoietin: new directions for the nervous systemCutting through the complexities of mTOR for the treatment of strokeIschaemic postconditioning: cardiac protection after the eventErythropoietin-mediated protection in kidney transplantation: nonerythropoietic EPO derivatives improve function without increasing risk of cardiovascular eventsErythropoietin: powerful protection of ischemic and post-ischemic brainShedding new light on neurodegenerative diseases through the mammalian target of rapamycinDriving neural regeneration through the mammalian target of rapamycinErythropoietin and mTOR: A "One-Two Punch" for Aging-Related Disorders Accompanied by Enhanced Life ExpectancyStrategy to Prime the Host and Cells to Augment Therapeutic Efficacy of Progenitor Cells for Patients with Myocardial InfarctionNew Insights for Oxidative Stress and Diabetes MellitusNovel applications of trophic factors, Wnt and WISP for neuronal repair and regeneration in metabolic diseaseIron behaving badly: inappropriate iron chelation as a major contributor to the aetiology of vascular and other progressive inflammatory and degenerative diseasesA new agonist of the erythropoietin receptor, Epobis, induces neurite outgrowth and promotes neuronal survivalDifferential modulation of angiogenesis by erythropoiesis-stimulating agents in a mouse model of ischaemic retinopathyWhat's New in Traumatic Brain Injury: Update on Tracking, Monitoring and TreatmentPrinciples of antegrade cerebral perfusion during arch reconstruction in newborns/infants.Erythropoietin-induced neurovascular protection, angiogenesis, and cerebral blood flow restoration after focal ischemia in mice.Erythropoietin over-expression protects against diet-induced obesity in mice through increased fat oxidation in musclesSoluble erythropoietin receptor contributes to erythropoietin resistance in end-stage renal diseaseFoxO3a governs early microglial proliferation and employs mitochondrial depolarization with caspase 3, 8, and 9 cleavage during oxidant induced apoptosis.EPO receptor gain-of-function causes hereditary polycythemia, alters CD34 cell differentiation and increases circulating endothelial precursors.Oxidative stress: Biomarkers and novel therapeutic pathways.Local erythropoietin and endothelial progenitor cells improve regional cardiac function in acute myocardial infarction.New strategies for Alzheimer's disease and cognitive impairment.Diabetes mellitus: channeling care through cellular discoveryFOXO3a governs early and late apoptotic endothelial programs during elevated glucose through mitochondrial and caspase signaling.Erythropoietin protects against rhabdomyolysis-induced acute kidney injury by modulating macrophage polarization.The "O" class: crafting clinical care with FoxO transcription factors.Early apoptotic vascular signaling is determined by Sirt1 through nuclear shuttling, forkhead trafficking, bad, and mitochondrial caspase activation.Synergistic neuroprotective therapies with hypothermia.Setup for human sera MALDI profiling: the case of rhEPO treatment.Wnt1, FoxO3a, and NF-kappaB oversee microglial integrity and activation during oxidant stress.Protective effects of erythropoietin and N-acetylcysteine on methotrexate-induced lung injury in rats.Erythropoietin levels are not independently associated with malaria-attributable severe disease in Mozambican children
P2860
Q24198115-1F4916DA-32FF-4494-9544-6D224082C0FCQ24200811-81D74A47-F2D4-4A5C-9559-89A199912B0EQ24241045-C2CE836B-89AD-4679-96FA-AFC6351D999BQ24307770-F9F884A8-6E6D-4719-85A4-88D5166D4362Q26777878-FAE1E7C7-9F0D-4F4C-BE5D-1101939C9A50Q26795544-6773E927-DD14-4221-958F-3E7767306BB7Q26828425-7918C74E-925E-4374-82C1-9F38E2FD2795Q26851291-79636977-B276-4B15-AA9F-0DFD37C9EA40Q26853129-DA1E3920-93C2-4666-84FC-9F8DDCFB3DD3Q26866295-3FC5A91E-289E-472C-B5DB-9C3913E23093Q26999392-1B48924B-4693-4DCF-8E62-EB60AD334B28Q27015640-80E4DE26-87AD-417A-B8D6-D495156A62BBQ27027516-A47735E1-0D56-4844-B83E-772777030E36Q28066377-8D0CD233-482C-4F92-859C-4E9BB3381B4EQ28077893-B8E7604E-5F78-43AA-9F97-A35CBF80323CQ28080679-A534D50B-A9FC-47DC-83D7-AB008E8A68FEQ28085715-28035321-2222-4AD3-BB5F-22CF586BBC43Q28388335-17346246-3E7B-49B4-A568-4ADE246BF498Q28575057-BB6C3C7E-1AD4-4CCC-88B5-5A51F65A3F87Q28750073-BCC5EBF6-EDC2-44A9-BC58-198AA81FB9C1Q30959630-2AEBC848-CBCC-4B51-93A8-C7B8C893EF6EQ31151812-CB54A8BC-5868-4191-B318-3C6836872D47Q33262324-19593FD9-A3E9-4D9D-AE9D-4B77E011E3CCQ33466769-E15AC407-5EC1-474E-B1FF-25B66A23902EQ33532601-5E5F516D-0D7F-4404-BB30-2A9A193F9EADQ33604706-CD71A420-A5EF-4239-ADAF-A621022C3595Q33654147-4848B851-0563-48CC-9579-58BF13096FACQ33682262-FA37B1E0-FFD1-4CFB-999F-F94F1D971CC2Q33694895-52C7E615-5A46-4910-8ABE-97AFCFCC32E9Q33717008-DC43F120-D3ED-4942-A936-96825D3C284EQ33749358-FF52DAE5-E248-4EEB-8A0A-82C5C3341750Q33802721-14CCCFE1-8E5F-408C-9F4B-EB6B29521525Q33815845-B2BD56FF-FF51-45D2-88CE-92099F005682Q33824809-F42098CE-CCFF-484B-A038-F2EF19874864Q33877687-08F4A3DF-6396-451A-9A42-9904823AAE69Q33943360-5C5F1E79-FBD3-44F8-BDAC-EB9C05A91F0AQ33943422-9E671355-4C02-401E-929B-C582FE35C351Q33945459-AEFBD677-3F06-4276-9399-783988522DBAQ33974376-98C7CA5A-222F-4AAA-A347-186B912D508AQ34017654-3F19D4B2-B4EE-432F-9E9C-FE7C4125E1C0
P2860
description
2005 nî lūn-bûn
@nan
2005年の論文
@ja
2005年論文
@yue
2005年論文
@zh-hant
2005年論文
@zh-hk
2005年論文
@zh-mo
2005年論文
@zh-tw
2005年论文
@wuu
2005年论文
@zh
2005年论文
@zh-cn
name
New avenues of exploration for erythropoietin.
@ast
New avenues of exploration for erythropoietin.
@en
type
label
New avenues of exploration for erythropoietin.
@ast
New avenues of exploration for erythropoietin.
@en
prefLabel
New avenues of exploration for erythropoietin.
@ast
New avenues of exploration for erythropoietin.
@en
P2093
P2860
P356
P1476
New avenues of exploration for erythropoietin.
@en
P2093
Kenneth Maiese
Zhao Zhong Chong
P2860
P356
10.1001/JAMA.293.1.90
P407
P577
2005-01-01T00:00:00Z